For example, we observed a dramatic increase in R-loops at Cyclin D1 (Figure 2E), which is amplified in up to 20% of breast cancers, the majority of which are ER-positive (Arnold and Papanikolaou, 2005; Osborne et al., 2004). Here, ESR1 is linked to breast carcinoma.